The pharmaceutical industry is in the midst of a monumental technological pivot, committing billions of dollars to the promise of artificial intelligence agent platforms in a bid to revolutionize its long-standing operational models. Spearheaded by landmark collaborations like the global
As a biopharma expert deeply embedded in the intersection of technology and research, Ivan Kairatov offers a pragmatic perspective on the integration of artificial intelligence into medicine. He navigates the hype surrounding large language models to focus on the rigorous clinical evaluation needed
Harnessing the immense chemical complexity of the natural world through the lens of artificial intelligence is fundamentally reshaping the landscape of modern medicine and biotechnology. This review explores the evolution of this approach, its key technological components, recent clinical
For families grappling with the hereditary specter of Huntington's disease, the certainty of a genetic diagnosis has always been shadowed by a profound and distressing uncertainty about when its devastating symptoms will begin. This devastating neurodegenerative disorder, caused by a known mutation
Today we’re joined by Ivan Kairatov, a biopharma expert at the intersection of technology and healthcare innovation. He’s here to break down a groundbreaking global study that uses artificial intelligence to untangle the complex web of factors driving cancer survival rates across nearly every
Today, we have the privilege of speaking with Ivan Kairatov, a biopharma expert at the forefront of technological innovation in research and development. His work delves into one of the most exciting intersections in modern medicine: the use of artificial intelligence to accelerate the fight
